0000950170-24-069973.txt : 20240606 0000950170-24-069973.hdr.sgml : 20240606 20240606170723 ACCESSION NUMBER: 0000950170-24-069973 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240605 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240606 DATE AS OF CHANGE: 20240606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACHIEVE LIFE SCIENCES, INC. CENTRAL INDEX KEY: 0000949858 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 954343413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 033-80623 FILM NUMBER: 241026352 BUSINESS ADDRESS: STREET 1: 22722 29TH DR. SE STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98021 BUSINESS PHONE: 425-686-1500 MAIL ADDRESS: STREET 1: 22722 29TH DR. SE STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20080821 FORMER COMPANY: FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950825 8-K 1 achv-20240605.htm 8-K 8-K
false0000949858BC0000949858dei:OtherAddressMember2024-06-052024-06-0500009498582024-06-052024-06-05

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 5, 2024

ACHIEVE LIFE SCIENCES, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware

033-80623

95-4343413

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

22722 29th Drive SE, Suite 100

Bothell, WA

 

98021

1040 West Georgia, Suite 1030

Vancouver, B.C., Canada

V6E 4H1

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (604) 210-2217

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of exchange on which registered

Common Stock, par value $0.001 per share

ACHV

The NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

 


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Annual Meeting of Stockholders of Achieve Life Sciences, Inc. (the “Company”) was held on June 5, 2024. The following is a brief description of each matter voted upon and the certified voting results.

(1)
Election of eight directors to serve until the Company’s next annual meeting or until the directors’ successors are duly elected and qualified:

 

For

Withhold

Broker
Non-Votes

John Bencich

14,570,909

 

 

 

456,303

 

 

 

10,246,712

Stuart Duty

 

 

14,088,063

 

 

 

939,149

 

 

 

10,246,712

 

Vaughn Himes

 

 

14,600,768

 

 

 

426,444

 

 

 

10,246,712

 

Cindy Jacobs

 

 

14,498,319

 

 

 

528,893

 

 

 

10,246,712

 

Thomas B. King

14,095,642

 

 

 

931,570

 

 

 

10,246,712

Bridget Martell

14,159,031

 

 

 

868,181

 

 

 

10,246,712

Thomas Sellig

14,605,590

 

 

 

421,622

 

 

 

10,246,712

Richard Stewart

14,516,198

 

 

 

511,014

 

 

 

10,246,712

Pursuant to the foregoing votes, the nominees listed above were elected as directors to serve on the Company’s board of directors.

(2)
Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024:

 

For

Against

Abstain

Broker
Non-votes

24,825,016

 

 

 

 

230,631

 

 

218,277

 

 

 

 

Pursuant to the foregoing votes, the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified.

 

________________________

 

 

 

 

 

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

ACHIEVE LIFE SCIENCES, INC.

 

Date: June 6, 2024

 

/s/ John Bencich

 

John Bencich

Chief Executive Officer (Principal Executive and Financial Officer)

 

 


EX-101.SCH 2 achv-20240605.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink Entity Addresses, Address Type [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Document Information [Table] Entity Central Index Key Entity Central Index Key Entity Address, State or Province Entity Address, State or Province Cover [Abstract] Entity Address, Country Entity Address, Country Entity Address, Address Line One Entity Address, Address Line One Amendment Flag Amendment Flag Entity Address, City or Town Entity Address, City or Town Document Type Document Type Title of 12(b) Security Title of 12(b) Security Address Type [Domain] Soliciting Material Soliciting Material Entity Address, Address Line Two Entity Address, Address Line Two Document Period End Date Document Period End Date Trading Symbol Trading Symbol Pre-commencement Tender Offer Pre-commencement Tender Offer Security Exchange Name Security Exchange Name Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Other Address [Member] Principal Address Securities Act File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number City Area Code City Area Code Local Phone Number Local Phone Number Document Information [Line Items] XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document and Entity Information
Jun. 05, 2024
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 05, 2024
Entity Registrant Name ACHIEVE LIFE SCIENCES, INC.
Entity Central Index Key 0000949858
Entity Emerging Growth Company false
Entity File Number 033-80623
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 95-4343413
Entity Address, Address Line One 22722 29th Drive SE
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Bothell
Entity Address, State or Province WA
Entity Address, Postal Zip Code 98021
City Area Code 604
Local Phone Number 210-2217
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol ACHV
Security Exchange Name NASDAQ
Principal Address  
Document Information [Line Items]  
Entity Address, Address Line One 1040 West Georgia
Entity Address, Address Line Two Suite 1030
Entity Address, City or Town Vancouver
Entity Address, State or Province BC
Entity Address, Country CA
Entity Address, Postal Zip Code V6E 4H1
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 2 24 1 false 1 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressStateOrProvince - achv-20240605.htm 8 achv-20240605.htm achv-20240605.xsd http://xbrl.sec.gov/dei/2024 false false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "achv-20240605.htm": { "nsprefix": "achv", "nsuri": "http://ir.achievelifesciences.com/20240605", "dts": { "inline": { "local": [ "achv-20240605.htm" ] }, "schema": { "local": [ "achv-20240605.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2024": 3 }, "contextCount": 2, "entityCount": 1, "segmentCount": 1, "elementCount": 30, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 29 }, "report": { "R1": { "role": "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_775ec587-512d-47e2-a9e3-c640ce7e0e74", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "achv-20240605.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_775ec587-512d-47e2-a9e3-c640ce7e0e74", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "achv-20240605.htm", "first": true, "unique": true } } }, "tag": { "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AddressTypeDomain", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentInformationLineItems", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentInformationTable", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "terseLabel": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_OtherAddressMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherAddressMember", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Other Address [Member]", "terseLabel": "Principal Address", "documentation": "Other address for entity" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://ir.achievelifesciences.com/20240605/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 13 0000950170-24-069973-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-069973-xbrl.zip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end XML 15 achv-20240605_htm.xml IDEA: XBRL DOCUMENT 0000949858 dei:OtherAddressMember 2024-06-05 2024-06-05 0000949858 2024-06-05 2024-06-05 false 0000949858 BC 8-K 2024-06-05 ACHIEVE LIFE SCIENCES, INC. DE 033-80623 95-4343413 22722 29th Drive SE Suite 100 Bothell WA 98021 1040 West Georgia Suite 1030 Vancouver CA V6E 4H1 604 210-2217 false false false false Common Stock, par value $0.001 per share ACHV NASDAQ false